{"transactions":[{"id":1112,"issuer":{"id":937,"kind":"organization","name":"Decoy Therapeutics Inc.","symbol":"DCOY"},"owners":[{"id":952,"kind":"person","name":"Lammers Paul","position":1,"cik":"0001457289","reported_name":"Lammers Paul","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-09-02T21:42:21.000Z","date":"2026-08-31","kind":"grant","planned":false,"acquired":true,"shares":2000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Restricted stock granted under the Decoy Therapeutics Inc. 2026 Equity Incentive Plan,  100 percent will vest on August 30, 2027."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Shares beneficially owned following the transaction have been adjusted to reflect the reverse stock splits effective on August 15, 2025 and March 6, 2026."}],"balance_after":2001,"source":{"system":"sec-edgar","filing":"0001457289-26-000003","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1615219/000145728926000003/ownership.xml","form_type":"4"}},{"id":1625227,"issuer":{"id":937,"kind":"organization","name":"Decoy Therapeutics Inc.","symbol":"DCOY"},"owners":[{"id":952,"kind":"person","name":"Lammers Paul","position":1,"cik":"0001457289","reported_name":"Lammers Paul","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-02-22T16:16:01.000Z","date":"2024-02-20","kind":"grant","planned":false,"acquired":true,"shares":20500,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":20500,"derivative":{"exercise_price":0.5711,"exercise_date":"2025-02-20","expiration_date":"2034-02-19","underlying":"Common Stock","underlying_shares":20500},"source":{"system":"sec-edgar","filing":"0001615219-24-000007","document":"wk-form4_1708636513.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1457289/000161521924000007/wk-form4_1708636513.xml","form_type":"4"}},{"id":2062491,"issuer":{"id":937,"kind":"organization","name":"Decoy Therapeutics Inc.","symbol":"DCOY"},"owners":[{"id":952,"kind":"person","name":"Lammers Paul","position":1,"cik":"0001457289","reported_name":"Lammers Paul","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-01-05T18:03:02.000Z","date":"2023-01-03","kind":"grant","acquired":true,"shares":1440,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Restricted stock granted under the Salarius Pharmaceuticals, Inc.2015 Equity Incentive Plan. 100% of the restricted stock will vest on January 2, 2024"}],"balance_after":1718,"source":{"system":"sec-edgar","filing":"0001615219-23-000010","document":"wf-form4_167295975197703.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1457289/000161521923000010/wf-form4_167295975197703.xml","form_type":"4"}},{"id":2428698,"issuer":{"id":937,"kind":"organization","name":"Decoy Therapeutics Inc.","symbol":"DCOY"},"owners":[{"id":952,"kind":"person","name":"Lammers Paul","position":1,"cik":"0001457289","reported_name":"Lammers Paul","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2022-01-21T16:05:04.000Z","date":"2022-01-20","kind":"grant","acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":30000,"derivative":{"exercise_price":0.48,"exercise_date":"2023-01-19","expiration_date":"2032-01-19","underlying":"Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0001615219-22-000005","document":"wf-form4_164279908733608.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1457289/000161521922000005/wf-form4_164279908733608.xml","form_type":"4"}},{"id":2956530,"issuer":{"id":937,"kind":"organization","name":"Decoy Therapeutics Inc.","symbol":"DCOY"},"owners":[{"id":952,"kind":"person","name":"Lammers Paul","position":1,"cik":"0001457289","reported_name":"Lammers Paul","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2020-12-04T16:55:26.000Z","date":"2020-12-02","kind":"grant","acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":30000,"derivative":{"exercise_price":0.74,"exercise_date":"2021-12-01","expiration_date":"2030-12-01","underlying":"Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0001615219-20-000115","document":"wf-form4_160711890918329.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1457289/000161521920000115/wf-form4_160711890918329.xml","form_type":"4"}},{"id":3195252,"issuer":{"id":937,"kind":"organization","name":"Decoy Therapeutics Inc.","symbol":"DCOY"},"owners":[{"id":952,"kind":"person","name":"Lammers Paul","position":1,"cik":"0001457289","reported_name":"Lammers Paul","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2020-03-25T18:01:58.000Z","date":"2020-03-23","kind":"grant","acquired":true,"shares":6000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Options granted are fully vested on March 23, 2021."}],"balance_after":6000,"derivative":{"exercise_price":0.61,"expiration_date":"2030-03-22","underlying":"Common Stock","underlying_shares":6000},"source":{"system":"sec-edgar","filing":"0001615219-20-000024","document":"wf-form4_158517370098647.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1457289/000161521920000024/wf-form4_158517370098647.xml","form_type":"4"}},{"id":3416208,"issuer":{"id":937,"kind":"organization","name":"Decoy Therapeutics Inc.","symbol":"DCOY"},"owners":[{"id":952,"kind":"person","name":"Lammers Paul","position":1,"cik":"0001457289","reported_name":"Lammers Paul","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2019-09-12T21:59:14.000Z","date":"2019-09-10","kind":"grant","acquired":true,"shares":3000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":3000,"derivative":{"exercise_price":8,"exercise_date":"2019-12-31","expiration_date":"2029-09-10","underlying":"Common Stock","underlying_shares":3000},"source":{"system":"sec-edgar","filing":"0001615219-19-000034","document":"wf-form4_156833993937396.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1457289/000161521919000034/wf-form4_156833993937396.xml","form_type":"4"}}]}